Suzanne Sawochka Hooper - Net Worth and Insider Trading
Suzanne Sawochka Hooper Net Worth
The estimated net worth of Suzanne Sawochka Hooper is at least $4 Million dollars as of 2024-04-18. Suzanne Sawochka Hooper is the EVP & General Counsel of Jazz Pharmaceuticals PLC and owns about 39,738 shares of Jazz Pharmaceuticals PLC (JAZZ) stock worth over $4 Million. Suzanne Sawochka Hooper is also the Director of NGM Biopharmaceuticals Inc and owns about 7,000 shares of NGM Biopharmaceuticals Inc (NGM) stock worth over $10,780. Details can be seen in Suzanne Sawochka Hooper's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Suzanne Sawochka Hooper has not made any transactions after 2019-04-08 and currently still holds the listed stock(s).
Transaction Summary of Suzanne Sawochka Hooper
Suzanne Sawochka Hooper Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Suzanne Sawochka Hooper owns 3 companies in total, including Eidos Therapeutics Inc () , NGM Biopharmaceuticals Inc () , and Jazz Pharmaceuticals PLC () .
Click here to see the complete history of Suzanne Sawochka Hooper’s form 4 insider trades.
Insider Ownership Summary of Suzanne Sawochka Hooper
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| Eidos Therapeutics Inc | 2020-08-06 | director | |
| NGM Biopharmaceuticals Inc | 2019-04-08 | director | |
| Jazz Pharmaceuticals PLC | 2019-02-27 | EVP and General Counsel |
Suzanne Sawochka Hooper Latest Holdings Summary
Suzanne Sawochka Hooper currently owns a total of 2 stocks. Among these stocks, Suzanne Sawochka Hooper owns 39,738 shares of Jazz Pharmaceuticals PLC (JAZZ) as of February 27, 2019, with a value of $4 Million and a weighting of 99.75%. Suzanne Sawochka Hooper also owns 7,000 shares of NGM Biopharmaceuticals Inc (NGM) as of April 8, 2019, with a value of $10,780 and a weighting of 0.25%.
Latest Holdings of Suzanne Sawochka Hooper
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| JAZZ | Jazz Pharmaceuticals PLC | 2019-02-27 | 39,738 | 107.10 | 4,255,940 |
| NGM | NGM Biopharmaceuticals Inc | 2019-04-08 | 7,000 | 1.54 | 10,780 |
Holding Weightings of Suzanne Sawochka Hooper
Suzanne Sawochka Hooper Form 4 Trading Tracker
According to the SEC Form 4 filings, Suzanne Sawochka Hooper has made a total of 0 transactions in Jazz Pharmaceuticals PLC (JAZZ) over the past 5 years. The most-recent trade in Jazz Pharmaceuticals PLC is the sale of 6,666 shares on February 27, 2019, which brought Suzanne Sawochka Hooper around $933,240.
According to the SEC Form 4 filings, Suzanne Sawochka Hooper has made a total of 0 transactions in NGM Biopharmaceuticals Inc (NGM) over the past 5 years. The most-recent trade in NGM Biopharmaceuticals Inc is the acquisition of 7,000 shares on April 8, 2019, which cost Suzanne Sawochka Hooper around $112,000.
Insider Trading History of Suzanne Sawochka Hooper
- 1
Suzanne Sawochka Hooper Trading Performance
GuruFocus tracks the stock performance after each of Suzanne Sawochka Hooper's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Suzanne Sawochka Hooper is -13.74%. GuruFocus also compares Suzanne Sawochka Hooper's trading performance to market benchmark return within the same time period. The performance of stocks bought by Suzanne Sawochka Hooper within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Suzanne Sawochka Hooper's insider trading performs compared to the benchmark.
Performance of Suzanne Sawochka Hooper
Average Relative Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Relative Return(%) | -8.93 | -13.74 | -36.67 | -4.74 | 29.26 | -0.02 |
| Relative Return to S&P 500(%) | -8.37 | -16.51 | -36.58 | 0.28 | 10.34 | -15.73 |
Suzanne Sawochka Hooper Ownership Network
Ownership Network List of Suzanne Sawochka Hooper
Ownership Network Relation of Suzanne Sawochka Hooper
Suzanne Sawochka Hooper Owned Company Details
What does Eidos Therapeutics Inc do?
Who are the key executives at Eidos Therapeutics Inc?
Suzanne Sawochka Hooper is the director of Eidos Therapeutics Inc. Other key executives at Eidos Therapeutics Inc include director & Chief Scientific Officer Uma Sinha , Senior Vice President & Finance Franco Valle , and Chief Business Officer Cameron Turtle .
Eidos Therapeutics Inc () Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Eidos Therapeutics Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Eidos Therapeutics Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Eidos Therapeutics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.
Eidos Therapeutics Inc Insider Transactions
Suzanne Sawochka Hooper Mailing Address
Above is the net worth, insider trading, and ownership report for Suzanne Sawochka Hooper. You might contact Suzanne Sawochka Hooper via mailing address: C/o Jazz Pharmaceuticals Plc, 5th Fl, Waterloo Exchange, Waterloo Rd, Dublin L2 4 L2.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
